41 Vitamin D level in cART treated patients is critical for HIV reservoir size
Saved in:
Main Authors: | A. Chéret (Author), A. Pasquet (Author), M. Lachatre (Author), P. Dujardin (Author), K. Bourdic (Author), Y. Quertainmont (Author), I. Alcaraz (Author), F. Boufassa (Author), C. Goujard (Author), E. Sauzer (Author), L. Bocquet (Author), C. Rouzioux (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phenotype and functionality of CD8+ T cells before and after cART are related to the viral reservoir size in people living with HIV-1
by: A. Czernikier, et al.
Published: (2019) -
HIV conserved region vaccine in early cART-treated subjects (BCN01): impact on immunogenicity and the latent reservoir
by: S. Morón-López, et al.
Published: (2015) -
Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART
by: Jimena Salido, et al.
Published: (2021) -
Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016) -
O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)